Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy

Cytotherapy

Volumn 15, Issue 6, 2013, Pages 663-672

  Reinders, Marlies E J ^a   Roemeling Van Rhijn, Marieke ^b   Khairoun, Meriem ^a   Lievers, Ellen ^a   De Vries, Dorottya K ^a   Schaapherder, Alexander F M ^a   Wong, San W S ^a   Zwaginga, Jaap Jan ^a   Duijs, Jacques M ^a   Van Zonneveld, Anton Jan ^a   Hoogduijn, Martin J ^b   Fibbe, Willem E ^a   De Fijter, Johan W ^a   Van Kooten, Cees ^a   Rabelink, Ton J ^a   Roelofs, Helene ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

autologous; mesenchymal stromal cells; transplant recipients

Indexed keywords

5' NUCLEOTIDASE; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GAMMA INTERFERON; INTERLEUKIN 10; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT RECIPIENT; GRANULOMATOSIS; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; INHIBITION KINETICS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MESENCHYMAL STROMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BONE MARROW CELLS; CELL- AND TISSUE-BASED THERAPY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 84877301536     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.01.010     Document Type: Article

References (53)

1. B.D. Humphreys, and J.V. Bonventre Mesenchymal stem cells in acute kidney injury Annu Rev Med 59 2008 311 325
2. M. Morigi, M. Introna, B. Imberti, D. Corna, M. Abbate, and C. Rota Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice Stem Cells 26 2008 2075 2082
3. Casiraghi F, Noris M, Remuzzi G. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Curr Opin Organ Transplant. [published online ahead of print September 24, 2010].
4. V. Ninichuk, O. Gross, S. Segerer, R. Hoffmann, E. Radomska, and A. Buchstaller Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice Kidney Int 70 2006 121 129
5. K. English, A. French, and K.J. Wood Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7 2010 431 442
6. M.E. Reinders, W.E. Fibbe, and T.J. Rabelink Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation Nephrol Dial Transplant 25 2010 17 24
7. M. Crisan, S. Yap, L. Casteilla, M. Corselli, T.S. Park, and G. Andriolo A perivascular origin for mesenchymal stem cells in multiple human organs Cell Stem Cell 3 2008 301 313
8. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, and D. Krause Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
9. F. Casiraghi, N. Azzollini, M. Todeschini, R.A. Cavinato, P. Cassis, and S. Solini Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation Am J Transplant 12 2012 2373 2383
10. M. Morigi, B. Imberti, C. Zoja, D. Corna, S. Tomasoni, and M. Abbate Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure J Am Soc Nephrol 15 2004 1794 1804
11. M. Franquesa, E. Herrero, J. Torras, E. Ripoll, M. Flaquer, and M. Gomá Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model Stem Cells Dev 21 2012 3125 3135
12. M. Franquesa, M.J. Hoogduijn, and C.C. Baan The impact of mesenchymal stem cell therapy in transplant rejection and tolerance Curr Opin Organ Transplant 17 2012 355 361
13. W. Zhang, C. Qin, and Z.M. Zhou Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model Transplant Proc 39 2007 3404 3408
14. C. Lange, F. Togel, H. Ittrich, F. Clayton, C. Nolte-Ernsting, and A.R. Zander Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats Kidney Int 68 2005 1613 1617
15. F. Togel, Z. Hu, K. Weiss, J. Isaac, C. Lange, and C. Westenfelder Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms Am J Physiol Renal Physiol 289 2005 F31 F42
16. M.J. Hoogduijn, F.C. Popp, A. Grohnert, M.J. Crop, M. van Rhijn, and A.T. Rowshani Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT) Transplantation 90 2010 124 126
17. B. Imberti, M. Morigi, and S. Tomasoni Insulin-like growth factor-1 sustains stem cell mediated renal repair J Am Soc Nephrol 18 2007 2921 2928
18. M. Morigi, A. Benigni, G. Remuzzi, and B. Imberti The regenerative potential of stem cells in acute renal failure Cell Transplant 15 2006 S111 S117
19. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506
20. M. Roemeling-van Rhijn, W. Weimar, and M.J. Hoogduijn Mesenchymal stem cells: application for solid-organ transplantation Curr Opin Organ Transplant 17 2012 55 62
21. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
22. M. Franquesa, M.J. Hoogduijn, O. Bestard, and J.M. Grinyo Immunomodulatory effect of mesenchymal stem cells on B Cells Front Immunol 3 2012 212
23. A.I. Caplan, and J.E. Dennis Mesenchymal stem cells as trophic mediators J Cell Biochem 98 2006 1076 1084
24. J. Tolar, K. Le Blanc, A. Keating, and B.R. Blazar Concise review: hitting the right spot with mesenchymal stromal cells Stem Cells 28 2010 1446 1455
25. J. Stagg Immune regulation by mesenchymal stem cells: two sides to the coin Tissue Antigens 69 2007 1 9
26. N. Perico, F. Casiraghi, M. Introna, E. Gotti, M. Todeschini, and R.A. Cavinato Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility Clin J Am Soc Nephrol 6 2011 412 422
27. J. Tan, W. Wu, X. Xu, L. Liao, F. Zheng, and S. Messinger Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial JAMA 307 2012 1169 1177
28. C. Bocelli-Tyndall, L. Bracci, G. Spagnoli, A. Braccini, M. Bouchenaki, and R. Ceredig Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro Rheumatology (Oxford) 46 2007 403 408
29. J. Larghero, D. Farge, A. Braccini, S. Lecourt, A. Scherberich, and E. Foïs Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis Ann Rheum Dis 67 2008 443 449
30. L.Y. Sun, H.Y. Zhang, X.B. Feng, Y.Y. Hou, L.W. Lu, and L.M. Fan Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus Lupus 16 2007 121 128
31. B. Arnulf, S. Lecourt, J. Soulier, B. Ternaux, M.N. Lacassagne, and A. Crinquette Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma Leukemia 21 2007 158 163
32. H.S. Juneja, and F.H. Gardner Functionally abnormal marrow stromal cells in aplastic anemia Exp Hematol 13 1985 194 199
33. H. Noh, M.R. Yu, H.J. Kim, J.S. Jeon, S.H. Kwon, and S.Y. Jin Uremia induces functional incompetence of bone marrow-derived stromal cells Nephrol Dial Transplant 27 2012 218 225
34. R. Kramann, S.K. Couson, S. Neuss, U. Kunter, M. Bovi, and J. Bornemann Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells Arterioscler Thromb Vasc Biol 31 2011 e45 e54
35. M. Roemeling-van Rhijn, M.E. Reinders, A. de Klein, H. Douben, S.S. Korevaar, and F.K. Mensah Mesenchymal stem cells derived from adipose tissue are not affected by renal disease Kidney Int 82 2012 748 758
36. U. Lakshmipathy, and R.P. Hart Concise review: MicroRNA expression in multipotent mesenchymal stromal cells Stem Cells 26 2008 356 363
37. C.S. Neal, M.Z. Michael, L.K. Pimlott, T.Y. Yong, J.Y. Li, and J.M. Gleadle Circulating microRNA expression is reduced in chronic kidney disease Nephrol Dial Transplant 26 2011 3794 3802
38. K. Chandrasekaran, D.S. Karolina, S. Sepramaniam, A. Armugam, E.M. Wintour, and J.F. Bertram Role of microRNAs in kidney homeostasis and disease Kidney Int 81 2012 617 627
39. C. Fehrer, and G. Lepperdinger Mesenchymal stem cell aging Exp Gerontol 40 2005 926 930
40. K. Stenderup, J. Justesen, C. Clausen, and M. Kassem Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells Bone 33 2003 919 926
41. Y. Wang, A. Zhang, Z. Ye, H. Xie, and S. Zheng Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion Transplant Proc 41 2009 4352 4360
42. F.C. Popp, E. Eggenhofer, P. Renner, P. Slowik, S.A. Lang, and H. Kasper Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate Transpl Immunol 20 2008 55 60
43. H.P. Zhou, D.H. Yi, S.Q. Yu, G.C. Sun, Q. Cui, and H.L. Zhu Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft Transplant Proc 38 2006 3046 3051
44. W. Ge, J. Jiang, M.L. Baroja, J. Arp, R. Zassoko, and W. Liu Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance Am J Transplant 9 2009 1760 1772
45. A.J. Nauta, G. Westerhuis, A.B. Kruisselbrink, E.G. Lurvink, R. Willemze, and W.E. Fibbe Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting Blood 108 2006 2114 2120
46. N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice Blood 106 2005 4057 4065
47. L. Zangi, R. Margalit, S. Reich-Zeliger, E. Bachar-Lustig, A. Beilhack, and R. Negrin Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells Stem Cells 27 2009 2865 2874
48. D.K. de Vries, A.F. Schaapherder, and M.E. Reinders Mesenchymal stromal cells in renal ischemia/reperfusion injury Front Immunol 3 2012 162
49. P. Cipriani, S. Guiducci, I. Miniati, M. Cinelli, S. Urbani, and A. Marrelli Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis Arthritis Rheum 56 2007 1994 2004
50. K.L. Covello, J. Kehler, H. Yu, J.D. Gordan, A.M. Arsham, and C.J. Hu HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes Dev 20 2006 557 570
51. Y.J. Jung, D.H. Kim, A.S. Lee, S. Lee, K.P. Kang, and S.Y. Lee Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury Am J Physiol Renal Physiol 297 2009 F952 F960
52. S. Gatti, S. Bruno, M.C. Deregibus, A. Sordi, V. Cantaluppi, and C. Tetta Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury Nephrol Dial Transplant 26 2011 1474 1483
53. R.A. Zager, A.C. Johnson, and S. Lund Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury Am J Physiol Renal Physiol 29 2009 F961 F970